Crossref
Key Points for Safe Antagonism Using Flumazenil in General Anesthesia with Remimazolam
THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · 15.11.2025 · 45 (6) · 608-616
DOI: 10.2199/jjsca.45.608 ↗Kurz gefasst
Fachartikel in der Zeitschrift THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA, erschienen am 15.11.2025. Verfasst von Shohei KANEKO.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
KANEKO, S. (2025). Key Points for Safe Antagonism Using Flumazenil in General Anesthesia with Remimazolam. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA, 45(6), 608-616. https://doi.org/10.2199/jjsca.45.608
Vancouver
KANEKO S. Key Points for Safe Antagonism Using Flumazenil in General Anesthesia with Remimazolam. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA. 2025;45(6):608-616. doi:10.2199/jjsca.45.608
BibTeX
@article{KANEKO2025,
author = {KANEKO, Shohei},
title = {Key Points for Safe Antagonism Using Flumazenil in General Anesthesia with Remimazolam},
journal = {THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA},
year = {2025},
volume = {45},
number = {6},
pages = {608--616},
doi = {10.2199/jjsca.45.608}
}
EUVIMED